BPA Call #47QSWA27F01DC

Premier & Companies Inc. Awarded BPA Call for Pepto-Bismol Chew Tablets

This award represents a purchase order under a Blanket Purchase Agreement (BPA) previously secured by Premier & Companies Inc. The BPA enables efficient acquisitions of essential government supplies across multiple federal agencies. In this particular BPA call, Premier & Companies Inc., a provider of a broad range of government critical supplies, is procuring Pepto-Bismol 5-symptom chewable tablets. These tablets address digestive health needs within government health programs or employee wellness initiatives. The acquisition enhances the agency's ability to maintain employee health and readiness, reflecting the ongoing importance of accessible over-the-counter medication in government operations. The scope includes delivery of chewable Pepto-Bismol packages in a specified quantity and timeframe, ensuring timely supply availability. This call was issued competitively under the existing BPA contract, affirming value and compliance with procurement standards. The performance period is concise, spanning approximately ten days in late 2026, allowing swift fulfillment and supply replenishment. The BPA mechanism supports streamlined procurement processes, crucial for expediting supplies and maintaining operational efficiency in the public sector. This call builds upon the foundation of the overarching IDV contract, solidifying Premier & Companies Inc.'s role as a key supplier to federal agencies.

Description

PEPTO BISMOL 5-SYMPTM CHEW 4CT

View original record